170 related articles for article (PubMed ID: 3900202)
1. G0 B cells activated by anti-mu acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase.
Proust JJ; Chrest FJ; Buchholz MA; Nordin AA
J Immunol; 1985 Nov; 135(5):3056-61. PubMed ID: 3900202
[TBL] [Abstract][Full Text] [Related]
2. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
[TBL] [Abstract][Full Text] [Related]
4. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
Kehrl JH; Muraguchi A; Fauci AS
Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
[TBL] [Abstract][Full Text] [Related]
5. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor.
Baeker TR; Rothstein TL
J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333
[TBL] [Abstract][Full Text] [Related]
7. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
[TBL] [Abstract][Full Text] [Related]
8. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
Phillips NE; Parker DC
J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
[TBL] [Abstract][Full Text] [Related]
10. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.
DeFranco AL; Raveche ES; Paul WE
J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499
[TBL] [Abstract][Full Text] [Related]
11. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
12. LPS-activated CBA/N mouse B cells respond to anti-Ig and a BSF-1-like factor.
Howard M; Pesavento P; Stein P
J Immunol; 1986 Jun; 136(12):4531-7. PubMed ID: 3486901
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
14. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
Seyschab H; Hoehn H; Rabinovitch PS; Chen U
Eur J Immunol; 1991 Sep; 21(9):2153-60. PubMed ID: 1909644
[TBL] [Abstract][Full Text] [Related]
15. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
16. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy.
Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ
J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209
[TBL] [Abstract][Full Text] [Related]
17. How relevant are growth and maturation factors to the B lymphocyte response induced by LPS?
Inazawa M; Shiozawa C; Fotedar R; Diener E
Lymphokine Res; 1985; 4(4):343-50. PubMed ID: 3876493
[TBL] [Abstract][Full Text] [Related]
18. Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).
Nakanishi K; Howard M; Muraguchi A; Farrar J; Takatsu K; Hamaoka T; Paul WE
J Immunol; 1983 May; 130(5):2219-24. PubMed ID: 6601148
[TBL] [Abstract][Full Text] [Related]
19. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
Berman JE; Zolla-Pazner S
J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
[TBL] [Abstract][Full Text] [Related]
20. Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA.
Thompson CB; Scher I; Schaefer ME; Lindsten T; Finkelman FD; Mond JJ
J Immunol; 1984 Nov; 133(5):2333-42. PubMed ID: 6207226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
